Status:
COMPLETED
Automated Robotic Maneuvering System (RMS) vs Manual Reposition Maneuver in Treatment of Benign Paroxysmal Positional Vertigo (BPPV)
Lead Sponsor:
Stratejik Yenilikci Girisimler Ltd.
Collaborating Sponsors:
Haseki Sultangazi Teaching and Research Hospital, University of Health Sciences
Conditions:
Benign Paroxysmal Positional Vertigo
Eligibility:
All Genders
18-80 years
Phase:
PHASE1
PHASE2
Brief Summary
Comparison of treatment efficacy of an automated robotic maneuvering system (RMS) repositioning chair versus manual positioning maneuvers in Benign Paroxysmal Positional Vertigo.
Detailed Description
The standard treatments for Benign Paroxysmal Positional Vertigo (BPPV) are manual positioning maneuvers. This method, beyond being costly and requiring extensive training, is a significant burden on ...
Eligibility Criteria
Inclusion
- Characteristic positional nystagmus (for BPPV)
- Positive Dix-Hallpike
- Positive supine roll test
- Positive Deep Head Hanging
- Vertigo-Dizziness Imbalance symptom scores compatible with BPPV
Exclusion
- Pregnant patients
- Patients who have taken vertigo suppressing agents (Dimenhydrinate) in the last 48 hours
- Patients taller than 200 cm (2.0 m)
- Patients who have had a cardiovascular or neurosurgical operation in the last month
- Patients with retinal detachment and/or glaucoma
- Lack of treatment cooperation
Key Trial Info
Start Date :
February 15 2022
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
April 23 2022
Estimated Enrollment :
75 Patients enrolled
Trial Details
Trial ID
NCT05352555
Start Date
February 15 2022
End Date
April 23 2022
Last Update
April 29 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Haseki Sultangazi Training and Research Hospital
Istanbul, Sultangazi, Turkey (Türkiye), 34265